Cellectar Biosciences Inc (NASDAQ:CLRB)

Delayed Data
As of Nov 26
 -0.024 / -3.20%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Cellectar Biosciences Inc have a median target of 5.50, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +657.58% increase from the last price of 0.73.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Cellectar Biosciences Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.33%
Growthannually 41.67%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.